Clinical Trial Update: Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia [Phase 2]

View source ↗

Summary

Phase 2 trial of transperineal intraprostatic injection of PRX302 under ultrasound guidance for benign prostatic hyperplasia completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• PRX302

Snippet

Sponsor: Sophiris Bio Corp | Conditions: Benign Prostatic Hyperplasia | Phase 2 | Status: COMPLETED | Results posted: 2013-10-28